Comparison of inhalation and oral exposure to the glyphosate herbicide: effects on respiratory system in rats Source: Virtual Congress 2021 – Environment and air pollution Year: 2021
Effect of acute passive cigarette smoke exposure on the single-dose pharmacokinetics of inhaled human insulin (Exubera®) Source: Eur Respir J 2006; 28: Suppl. 50, 800s Year: 2006
Safety, tolerability and pharmacokinetics (PK) of repeated doses of GSK573719 inhalation powder, a new long-acting muscarinic antagonist, in healthy adults Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Dose escalation study in healthy male subjects to investigate safety, tolerability and systemic exposure of orally inhaled single-doses of AP301 Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
Safety, dose finding and efficacy of ectoine inhalation solution in patients with mild asthma Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010
High nicotine exposure in rodents is unlikely to inform about its toxicity in humans Source: Eur Respir J, 54 (2) 1801073; 10.1183/13993003.01073-2018 Year: 2019
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma Source: Eur Respir J 2006; 28: 1042-1050 Year: 2006
Pharmacokinetics and local tolerance of an IL-4/IL-13 antagonist inhalation powder in humans Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Hepatotoxic reactions in rats after administration of component schemes of reserve Anti-TB drugs with different safety profile Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
Exposure biomarkers in a pig model of chlorine inhalation injury Source: Virtual Congress 2020 – Air pollution as a cause of respiratory disease Year: 2020
Repeated daily inhalations of ciclesonide, compared to single inhalation, do not lead to increased systemic exposure Source: Eur Respir J 2003; 22: Suppl. 45, 282s Year: 2003
Pharmacokinetics and pre-clinical efficacy of ralinepag (APD811) in humans and rats Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension Year: 2017
Pharmacokinetic (PK) and pharmacodynamic (PD) data for inhaled and intranasal corticosteroids (CS) reassessed using a physiological PK/PD model Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001
Complete inhalation modelling: Human validation of an inhaled drug simulation tool Source: Eur Respir J 2003; 22: Suppl. 45, 532s Year: 2003
Intrapleural administration of pemetrexed: a pharmacokinetic study in an animal model Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008
Comparison of the pharmacokinetic, pharmacodynamic, and safety profiles of three different formulations of intravenous epoprostenol sodium Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
The antiinflammatory and antioxidant effect of tiotropium bromide in subacute cigarette exposure mouse model Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Safety, tolerability, pharmacokinetics and pharmacodynamics after repeated once or twice daily RVT-1201, a TPH inhibitor for treatment of PAH Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019
Safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of GSK573719 inhalation powder in healthy subjects Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Long-term clinical effect of inhalation method with lowered tongue. Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020